TransMedics (TMDX) Shareholder's Equity Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.50% |
| Dec 31, 2025 | 106.95% |
| Sep 30, 2025 | 69.21% |
| Jun 30, 2025 | 67.52% |
| Mar 31, 2025 | 66.99% |
| Dec 31, 2024 | 66.62% |
| Sep 30, 2024 | 66.00% |
| Jun 30, 2024 | 30.77% |
| Mar 31, 2024 | -17.21% |
| Dec 31, 2023 | -26.78% |
| Sep 30, 2023 | -32.68% |
| Jun 30, 2023 | 185.18% |
| Mar 31, 2023 | 221.52% |
| Dec 31, 2022 | 176.14% |
| Sep 30, 2022 | 139.16% |
| Jun 30, 2022 | -42.78% |
| Mar 31, 2022 | -38.66% |
| Dec 31, 2021 | -34.69% |
| Sep 30, 2021 | -28.30% |
| Jun 30, 2021 | -21.78% |
| Mar 31, 2021 | 109.23% |
| Dec 31, 2020 | 90.11% |
| Sep 30, 2020 | 72.60% |
| Jun 30, 2020 | 59.86% |
| Mar 31, 2020 | 123.45% |
| Dec 28, 2019 | 128.43% |
| Sep 28, 2019 | 134.37% |
| Jun 29, 2019 | 139.61% |
| Mar 30, 2019 | -14.66% |